PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 23(3): 213-221 2003
© 2003 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welten, A.
Right arrow Articles by Beelen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welten, A.
Right arrow Articles by Beelen, R.
Peritoneal Dialysis International, Vol 23, Issue 3, 213-221
Copyright © 2003 by International Society for Peritoneal Dialysis

Articles

Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response

AG Welten, CG Schalkwijk, PM ter Wee, S Meijer, J van den Born, and RJ Beelen

Department of Molecular Cell Biology, VU University Medical Center, Amsterdam, The Netherlands. aga.welten.cell@med.vu.nl

BACKGROUND: Fluids commonly used for peritoneal dialysis (PD) have a low pH and a high glucose content. Furthermore, heat sterilization of dialysis fluids degrades some of the glucose into glucose degradation products (GDPs), such as methylglyoxal (MGO) and 3-deoxyglucosone (3-DG). Mesothelial cells (MCs) form the first line in the peritoneal cavity and are constantly exposed to these nonphysiological conditions. Since MCs play an important role in the regulation of inflammatory responses in the peritoneal cavity, we studied the kinetics of MC uptake of highly purified GDP species, along with their effect on various cellular biological and immunological parameters. METHODS: Methylglyoxal and 3-DG were purified and added to MC cultures. Complexing to medium components or uptake by MCs was analyzed over time by HPLC of the culture supernatant and by immunocytochemistry of MCs for MGO-modified proteins. Furthermore, MCs were exposed to a single dose of MGO or 3-DG and analyzed for apoptosis, proliferation by MTT assay, and [3H]-thymidine incorporation. Incorporation of [35S]-methionine was determined in order to analyze de novo protein synthesis. Expression of the adhesion molecules intercellular adhesion molecule-1 (ICAM-1), CD44, and vascular cell adhesion molecule-1 (VCAM-1) was analyzed by cell-bound ELISA. Effects of MGO and 3-DG on cytokine production were also analyzed. RESULTS: Substitution of MGO and 3-DG in culture medium resulted in a spontaneous decrease in MGO over time, whereas 3-DG levels decreased minimally. The concentration of these GDPs was more reduced in the presence of MCs, indicating binding to and/or uptake by MCs of these GDPs. Mesothelial cells that had been cultured in the presence of MGO showed positive staining with a monoclonal that specifically recognizes MGO-modified proteins, demonstrating complexing to mesothelial cellular proteins. Cell-bound ELISA showed a two- to three-fold induction of expression of VCAM-1 by MGO and 3-DG; the expression of ICAM-1 and CD44 was not changed. Mesothelial cells showed a twofold increase in interleukin (IL)-6 and IL-8 production after exposure to 3-DG. Furthermore, incubation with MGO and 3-DG induced apoptosis and reduced the proliferation of cells, but did not influence protein synthesis. CONCLUSIONS: In the current report we demonstrate that MCs take up MGO and 3-DG and form early advanced glycation end-products. Upon short exposure to a single GDP, MCs react with enhanced cytotoxic damage and a proinflammatory response, evidenced by increased VCAM-1 expression and elevated production of IL-6 and IL-8.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
B. Santamaria, A. C. Ucero, A. Reyero, R. Selgas, M. Ruiz-Ortega, M. Catalan, J. Egido, and A. Ortiz
3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3307 - 3315.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. C. K. Leung, L. Y. Y. Chan, K. Y. Tam, S. C. W. Tang, M. F. Lam, A. S. Cheng, K. M. Chu, and K. N. Lai
Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis
Nephrol. Dial. Transplant., September 19, 2008; (2008) gfn524v1.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Zareie, G.-J. Tangelder, P. M. ter Wee, L. H. Hekking, A. A. van Lambalgen, E. D. Keuning, I. L. Schadee-Eestermans, C. G. Schalkwijk, R. H. Beelen, and J. van den Born
Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2783 - 2792.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Fusshoeller, M. Plail, B. Grabensee, and J. Plum
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2101 - 2106.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. G. A. Welten, M. Zareie, J. van den Born, P. M. ter Wee, C. G. Schalkwijk, B. A. J. Driesprong, F. P. J. Mul, P. L. Hordijk, R. H. J. Beelen, and L. H. P. Hekking
In vitro and in vivo models for peritonitis demonstrate unchanged neutrophil migration after exposure to dialysis fluids
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 831 - 839.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2003 by Multimed Inc.